Limp 2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
LIMP-2 (Lysosomal Integral Membrane Protein 2) is a lysosomal membrane protein encoded by the SCARB2 gene. It serves as a receptor for glucocerebrosidase (GCase) trafficking to lysosomes and is involved in lysosomal function and autophagy.
| Property |
Value |
| Protein Name |
Lysosomal Integral Membrane Protein 2 |
| Gene Symbol |
SCARB2 |
| UniProt ID |
Q9Y5R4 |
| Molecular Weight |
~60 kDa |
| Structure |
12 transmembrane domains |
| Expression |
Ubiquitous, high in brain |
LIMP-2 has several critical cellular functions:
- GCase Receptor: Binds and traffics glucocerebrosidase to lysosomes
- Mannose-6-phosphate-independent trafficking: Unique receptor system
- Enzyme Delivery: Critical for glucocerebrosidase activity
- Lysosomal Integrity: Maintains lysosomal function
- Autophagosome-Lysosome Fusion: Involved in autophagy
- Lysosomal Biogenesis: Regulates lysosome number
- Protein Degradation: Essential for degradation pathways
- Endocytosis: Mediates cargo uptake
- Phagosome Maturation: Important for phagolysosome formation
- Neuronal Function: Synaptic vesicle trafficking
- Genetic Risk: SCARB2 variants increase PD risk
- GCase Trafficking: Disrupted in PD brain
- α-Synuclein Interaction: GCase deficiency affects α-syn clearance
- Therapeutic Target: Small molecule chaperones
- Biomarker: LIMP-2 levels as PD marker
- Type 1: LIMP-2 mutations cause GCase deficiency
- Parkinsonism: Increased PD risk in Gaucher patients
- Neuropathic Forms: May involve LIMP-2 dysfunction
- α-Synuclein Pathology: LIMP-2 affects aggregation
- Lysosomal Dysfunction: Common feature
- SCARB2 Mutations: Cause progressive myoclonus epilepsy
- Ataxia: Associated with SCARB2 variants
- GCase chaperones: Ambroxol, migalastat
- Gene therapy: Increase LIMP-2 expression
- Small molecule modulators: Enhance trafficking
- GCase + LIMP-2: Synergistic effects
- Autophagy enhancers: Complement LIMP-2 function
LIMP-2 serves as a critical sorting receptor for the delivery of glucocerebrosidase (GCase) from the endoplasmic reticulum to the lysosome. The mechanism involves:
- ER Export: LIMP-2 binds GCase in the ER via its luminal domain
- Golgi Transport: The LIMP-2-GCase complex traverses the Golgi apparatus
- Lysosomal Delivery: LIMP-2 delivers GCase to the lysosome via mannose-6-phosphate-independent targeting
- Receptor Recycling: LIMP-2 returns to the ER or Golgi for another round of transport
LIMP-2 contains multiple functional domains:
- N-terminal signal peptide: ER targeting
- Luminal domain: GCase binding site (LIMP-2 receptor domain)
- Transmembrane domain: Single pass membrane protein
- Cytoplasmic tail: Contains sorting signals for intracellular trafficking
LIMP-2 is widely expressed across tissues with highest levels in:
In the brain, LIMP-2 expression is particularly high in dopaminergic neurons of the substantia nigra, making it relevant to Parkinson's disease research.
- LIMP-2 null mice show reduced GCase activity in tissues
- Neurological phenotypes including accumulation of glycolipids
- Enhanced susceptibility to neurotoxic insults
- Preclinical relevance to GBA-associated PD
- LIMP-2 overexpressing mice
- Conditional knockout in specific neuronal populations
- Crossbreeding with alpha-synuclein transgenic mice
The study of Limp 2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.